Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-064558)

Filing Details

Accession Number:: 0000950170-25-064558
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-06 16:42:23
Reporting Period:: 2025-05-02

Filing Date:: 2025-05-06
Accepted Time:: 2025-05-06 16:42:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1743881	Bridgebio Pharma Inc.	BBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1679076	Andrew Lo	C/O Bridgebio Pharma, Inc. 3160 Porter Dr., Suite 250 Palo Alto CA 94304		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-05-02	100,000	$38.50	105,583	No	4	S	Indirect	By Andrew W. Lo and Nancy N. Lo JTWROS

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Andrew W. Lo and Nancy N. Lo JTWROS

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	48,099	Direct

Footnotes

Represents the weighted average sale price of the shares sold from $38.155 to $38.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.